Free Trial

Avalo Therapeutics (AVTX) Insider Trading & Ownership

$10.79
-0.13 (-1.19%)
(As of 05/22/2024 ET)

Avalo Therapeutics (NASDAQ:AVTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.20%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$93,110.40
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$1.68 M
Get AVTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Avalo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AVTX Insider Buying and Selling by Quarter

Avalo Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/26/2023Armistice Capital, LlcMajor ShareholderSell11,442$146.40$1,675,108.80  
6/20/2023Caissa Capital Management Ltd.Major ShareholderBuy8$993.60$7,948.80  
6/16/2023Caissa Capital Management Ltd.Major ShareholderBuy12$936.00$11,232.00  
6/14/2023Caissa Capital Management Ltd.Major ShareholderBuy25$835.20$20,880.00  
6/12/2023Caissa Capital Management Ltd.Major ShareholderBuy8$1,041.60$8,332.80  
6/9/2023Christopher Ryan SullivanCFOBuy2$820.80$1,641.60  
6/9/2023Garry Arthur NeilCEOBuy16$820.80$13,132.80  
5/30/2023Caissa Capital Management Ltd.Major ShareholderBuy2$688.80$1,377.60  
5/25/2023Caissa Capital Management Ltd.Major ShareholderBuy8$664.80$5,318.40  
5/22/2023Caissa Capital Management Ltd.Major ShareholderBuy29$801.60$23,246.40  
(Data available from 1/1/2013 forward)

AVTX Insider Trading Activity - Frequently Asked Questions

Who is on Avalo Therapeutics's Insider Roster?

The list of insiders at Avalo Therapeutics includes Armistice Capital, Llc, Caissa Capital Management Ltd., Christopher Ryan Sullivan, Garry Arthur Neil, H Jeffrey Wilkins, and Schond L Greenway. Learn more on insiders at AVTX.

What percentage of Avalo Therapeutics stock is owned by insiders?

0.20% of Avalo Therapeutics stock is owned by insiders. Learn more on AVTX's insider holdings.

Which Avalo Therapeutics insiders have been buying company stock?

The following insiders have purchased AVTX shares in the last 24 months: Caissa Capital Management Ltd. ($353,508.00), Christopher Ryan Sullivan ($1,641.60), and Garry Arthur Neil ($21,619.20).

How much insider buying is happening at Avalo Therapeutics?

Insiders have purchased a total of 535 AVTX shares in the last 24 months for a total of $376,768.80 bought.

Which Avalo Therapeutics insiders have been selling company stock?

The following insider sold AVTX shares in the last 24 months: Armistice Capital, Llc ($1,675,108.80).

How much insider selling is happening at Avalo Therapeutics?

Insiders have sold a total of 11,442 Avalo Therapeutics shares in the last 24 months for a total of $1,675,108.80 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:AVTX) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners